| Acetylon Pharmaceuticals, Inc. |
iRobot |
| Achaogen |
J.
Robert Scott Executive Search |
| Advanced Technology Ventures |
Joslin Diabetes Center |
| Alexandria
Real Estate Equities |
Kew Group |
| Allegro
Diagnostics |
Lilly
Ventures |
| Anchor
Therapeutics |
MacDougall Biomedical
Comm. |
| Arsenal
Medical |
Mass Life Sciences Center |
| Ascension Health Ventures |
MDInteractive |
| Astrazeneca |
Merck
& Co., Inc. |
| Atlas Venture |
MPM Capital |
| Avecia Biotechnology Inc. |
NeurAxon |
| AVEO Pharmaceuticals, Inc. |
Norwich
Ventures |
| Biogen
Idec |
Novartis Molecular Diagnostics |
| Bioventures
Investors |
Novartis Venture Funds |
| Boston
Heart Lab |
Novelos Therapeutics, Inc. |
| Boston
Scientific |
On-Q-ity, Inc. |
| Celldex Therapeutics, Inc. |
Partners HealthCare |
| Center for Connected Health |
Pfizer |
| Clinquest
Inc. |
Pharmacogenetics
Clin. Adv. Board |
| Ctr. for
Genetics and Genomics |
Polaris Venture Partners |
| Daktari Diagnostics, Inc. |
Proteostasis Therapeutics, Inc. |
| deCode genetics |
PTC
Therapeutics |
| Dicerna Pharmaceuticals, Inc. |
Pure
Communications Inc. |
| Eli Lilly and Company |
Rhapsody
Biologics |
| Enlight
Biosciences |
RiboNovix, Inc. |
| ENTRA Pharmaceuticals, Inc. |
RMG
Associates, LLC |
| Epic
Genetics LLC |
Satori Pharmaceuticals Inc. |
| Exelixis, Inc. |
Silicon Valley Bank |
| Fidelity BioSciences |
Stromedix, Inc. |
| Foley
and Lardner LLP |
Synta Pharmaceuticals |
| Forma
Therapeutics |
The GI Company Inc. |
| Gene Network Sciences |
The Ingber
Laboratory |
| Genzyme |
TVM Capital |
| GI Dynamics, Inc. |
Vertex Pharmaceuticals |
| Halloran
Consulting Group |
Waltham Technologies |
| Ignite Institute |
Zafgen |
| Interlace
Medical |
ZOLL Medical |
|
|
|
|
|
|
|
|
|
|
|
|
